What is Protagonist Therapeutics's change in income taxes?

Protagonist Therapeutics (PTGX) reported change in income taxes of -$1.89M in Q2 2025.

What does change in income taxes mean?

Change in income tax receivables and payables, reflecting timing between tax accruals and cash payments.

Protagonist Therapeutics PTGX Change in Income Taxes

Change in Income Taxes at other companies

Bristol-Myers SquibbBMY

$187M+246%

AmgenAMGN

$71M-31.7%

Other financials

Income statement

See full

Revenue$56.4M+99.0%

Operating income-$3.6M+81.1%

Net income$3.8M+132%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$193.7M+38.7%

Total debt$9.8M-13.9%

Total equity$655.5M-4.9%

Total assets$697.5M-6.0%

Cash flow

See full

Operating cash flow-$48.9M-139%

CapEx$215.0K-60.6%

Free cash flow-$49.2M-139%

Valuation

See full

Market cap$7.26B+127%

Enterprise value$7.07B+130%

P/S98×+82.6×

Profitability

See full

Operating margin-192.4%-205pp

Net margin-154.9%-182pp

FCF margin-12,264.3%-12,527pp

Returns & leverage

See full

Return on equity-17.1%-26.1pp

Debt / equity0×0.0×

Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable.

The official record: Protagonist Therapeutics’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's change in income taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Protagonist Therapeutics's change in income taxes?: Protagonist Therapeutics (PTGX) reported change in income taxes of -$1.89M in Q2 2025.
What does change in income taxes mean?: Change in income tax receivables and payables, reflecting timing between tax accruals and cash payments.